Skip to main content
Top
Published in:

01-12-2025 | REVIEW

Circadian Rhythms in Aging and Age-Related Neurogenerative Disease

Authors: Kirsi-Marja Zitting, Robin K. Yuan

Published in: Current Sleep Medicine Reports | Issue 1/2025

Login to get access

Abstract

Purpose of Review

Age-related changes in the circadian timing system may play a role in the development of disorders in older age. We review key aspects of the human circadian system that change with aging, discuss recent evidence of how changes in sleep and circadian rhythms manifest in neurodegenerative diseases, and summarize research on new therapies.

Recent Findings

Several mechanisms have been proposed to underlie age-related changes in sleep and circadian rhythmicity. These mechanisms include changes in the suprachiasmatic nucleus, melatonin production, and light sensitivity as well as impaired glymphatic drainage, buildup of amyloid-beta, hypoxia from sleep-disordered breathing, and increased levels of orexin. While light-based therapies and lifestyle interventions have been under investigation for years, newer interventions include treatment with orexin antagonists and gamma stimulation to improve sleep and circadian rhythmicity.

Summary

Despite growing interest, our understanding of how sleep and circadian rhythms contribute to the development of age-related neurodegenerative diseases is still limited. More research is needed to understand the bidirectional relationship between circadian rhythms, sleep, and neurodegenerative diseases to develop targeted interventions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Circadian Rhythms in Aging and Age-Related Neurogenerative Disease
Authors
Kirsi-Marja Zitting
Robin K. Yuan
Publication date
01-12-2025
Publisher
Springer International Publishing
Published in
Current Sleep Medicine Reports / Issue 1/2025
Electronic ISSN: 2198-6401
DOI
https://doi.org/10.1007/s40675-025-00336-w

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest